Drug recall · May 1, 2013
Propofol Injectable Emulsion recall
Why: Presence of Particulate Matter: A single visible particulate was identified during a retain sample inspection.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.
- Lots / codes
Lot #: 11-185-DJ*, 11-196-DJ*, Exp 1NOV2013; * may be followed by 01 or 02
- Quantity
- 245,250 vials
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide and Puerto Rico
- Initiated
- April 8, 2013 · Voluntary: Firm initiated
- Classified
- April 24, 2013
- Reported
- May 1, 2013
- Ended
- November 3, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Propofol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.